Indication

Life-threatening ventricular tachycardia

Life-threatening ventricular tachycardia is a high-acuity cardiovascular arrhythmia originating within the ventricular myocardium or His-Purkinje conduction system. Read more about Life-threatening ventricular tachycardia

144 drugs 82 manufacturers

Advertisement

Drugs that treat it

Common Life-threatening ventricular tachycardia therapies.

Showing 91–99 of 144 drugs

FLECAINIDE ACETATE

ANTIARRHYTHMIC - CLASS IC·PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA·+4
EPIC PHARMA LLC

QUINIDINE SULFATE

ANTIARRHYTHMIC - CLASS IA·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+3
EPIC PHARMA LLC

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
AVPAK

FLECAINIDE ACETATE

ANTIARRHYTHMIC - CLASS IC·PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA·+4
AVPAK

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
A-S MEDICATION

FLECAINIDE ACETATE

ANTIARRHYTHMIC - CLASS IC·PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA·+4
A-S MEDICATION

PROPAFENONE HCL

ANTIARRHYTHMIC - CLASS IC·PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA·+4
A-S MEDICATION

SOTALOL (sotalol HCl)

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
A-S MEDICATION
Filter & compare in the drug finder →Opens the drug finder with Life-threatening ventricular tachycardia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Life-threatening ventricular tachycardia.

Life-threatening ventricular tachycardia is a high-acuity cardiovascular arrhythmia originating within the ventricular myocardium or His-Purkinje conduction system.

It is pathologically characterized by three or more consecutive premature ventricular depolarizations at rates typically exceeding 100 beats per minute, commonly driven by myocardial reentry circuits, abnormal automaticity, or triggered activity related to structural heart disease or ischemic scarring.

The rapid rate critically compromises ventricular filling, stroke volume, and systemic perfusion, manifesting as profound hemodynamic instability, syncope, hypotension, or acute cardiogenic collapse.

Primarily affecting patients with ischemic cardiomyopathy, structural heart abnormalities, or cardiac channelopathies, this clinical state carries an immediate risk of precipitating cardiac arrest and sudden cardiac death via degeneration into ventricular fibrillation.

Personalize your experience

Follow Life-threatening ventricular tachycardia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it